Commission Implementing Regulation (EU) 2023/2384 of 29 September 2023 amending Implementing Regulation (EU) 2018/1287 to make an administrative change to the Union authorisation of the biocidal product family Quat-Chem’s iodine based products
Commission Implementing Regulation (EU) 2023/2384of 29 September 2023amending Implementing Regulation (EU) 2018/1287 to make an administrative change to the Union authorisation of the biocidal product family Quat-Chem’s iodine based products(Text with EEA relevance)THE EUROPEAN COMMISSION,Having regard to the Treaty on the Functioning of the European Union,Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal productsOJ L 167, 27.6.2012, p. 1., and in particular Article 50(2) thereof,Whereas:(1)On 24 September 2018, Commission Implementing Regulation (EU) 2018/1287Commission Implementing Regulation (EU) 2018/1287 of 24 September 2018 granting a Union authorisation for the biocidal product family Quat-Chem’s iodine based products (OJ L 240, 25.9.2018, p. 10). granted a Union authorisation with authorisation number EU-0018496-0000 to Quatchem Ltd for the making available on the market and use of the biocidal product family "Quat-Chem’s iodine based products".(2)On 14 December 2020, Quatchem Ltd submitted a notification to the European Chemicals Agency ("the Agency"), in accordance with Article 11(1) of Commission Implementing Regulation (EU) No 354/2013Commission Implementing Regulation (EU) No 354/2013 of 18 April 2013 on changes of biocidal products authorised in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 109, 19.4.2013, p. 4)., regarding an administrative change to the Union authorisation for the biocidal product family "Quat-Chem’s iodine based products" referred to in Title 1, Section 1, of the Annex to that Regulation.(3)Quatchem Ltd proposed to transfer the authorisation to a new holder established in the European Economic Area as set out in Title 1, Section 1, point 3, of the Annex to Implementing Regulation (EU) No 354/2013. The notification was recorded under case number BC-VP063434-15 in the Register for Biocidal Products.(4)On 29 April 2022, the Agency submitted an opinionECHA opinion on an administrative change of the Union authorisation of QUAT-CHEM’s iodine based products of 13 August 2021, Opinion No UTR-C-1527940-77-00/F, https://echa.europa.eu/opinions-on-union-authorisation to the Commission on the proposed change, in accordance with Article 11(3) of Implementing Regulation (EU) No 354/2013. The opinion concludes that the amendment to the existing authorisation sought by the authorisation holder falls under Article 50(3), point (a), of Regulation (EU) No 528/2012, that the parties have agreed to the transfer of the authorisation, that the prospective new authorisation holder is established in the Union, and that after the implementation of the changes, the conditions of Article 19 of that Regulation are still met. On the same date, the Agency transmitted to the Commission the revised summary of the biocidal product characteristics in all the official languages of the Union in accordance with Article 11(6) of Implementing Regulation (EU) No 354/2013.(5)The Commission concurs with the opinion of the Agency and therefore considers it appropriate to amend the Union authorisation of the biocidal product family "Quat-Chem’s iodine based products".(6)Save for the amendment regarding the transfer of the authorisation to a new holder, all other information included in the summary of the biocidal product characteristics of "Quat-Chem’s iodine based products" as set out in the Annex to Implementing Regulation (EU) 2018/1287 remains unchanged,HAS ADOPTED THIS REGULATION: